Han, R., Yang, H., Lu, L., & Lin, L. (2021). Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis. Nature Portfolio.
Cita Chicago Style (17a ed.)Han, Rui, Hongxing Yang, Lingeng Lu, y Lizhu Lin. Tiliroside as a CAXII Inhibitor Suppresses Liver Cancer Development and Modulates E2Fs/Caspase-3 Axis. Nature Portfolio, 2021.
Cita MLA (8a ed.)Han, Rui, et al. Tiliroside as a CAXII Inhibitor Suppresses Liver Cancer Development and Modulates E2Fs/Caspase-3 Axis. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.